29th Annual Controversies in the Management of the Patient with HIV

Fiona Gispen is an Infectious Diseases physician-scientist and Assistant Professor of Medicine at Weill Cornell Medicine. Her clinical work focuses on HIV primary care, while her research examines infections related to substance use. Her work uses large administrative and clinical datasets to evaluate treatment strategies, care transitions, and outcomes for people who use drugs, with a particular focus on improving equitable access to effective, patient-centered infectious diseases care.

Rajesh T. Gandhi, M.D. is a Professor of Medicine at Harvard Medical School and Principal Investigator and Co-Director of the Harvard University Center for AIDS Research (CFAR). Dr. Gandhi is Vice-Chair of the ACTG. He is also the site leader of the Massachusetts General Hospital (MGH) Clinical Research Site in the ACTG. He is the Director of HIV Education at MGH. Dr. Gandhi is Vice-Chair of the Infectious Diseases Society of America (IDSA) Covid-19 Treatment Guidelines Panel. He is also Chair of the International Antiviral Society-USA Panel on Antiretroviral Drugs for Treatment and Prevention of HIV in Adults. Dr. Gandhi is the Lead Editor for Infectious Diseases, NEJM Clinician. Dr. Gandhi graduated from Harvard Medical School, completed his medical residency and chief residency at Brigham and Women’s Hospital, and his infectious diseases fellowship training at Johns Hopkins Hospital.

has been actively involved in research, treatment and education aimed at combating HIV/AIDS for decades. Dr. Wright is currently the Vice Chair for Obstetrics, and Professor of Obstetrics & Gynecology and Women’s Health at Montefiore Einstein in New York and the Interim Maternal Fetal Medicine Division Director.He also is the Montefiore Medical Staff President.Dr. Wright received a Bachelor’s Degree from Emory University, a Doctor of Medicine degree from the University of Pennsylvania, completed residency at the University of California – Irvine, and completed a Maternal Fetal Medicine fellowship at Montefiore Einstein.He currently serves as the co-chair of the NIH/CDC/DHHS Perinatal HIV Guidelines Panel.He has conducted research as an investigator with the Women’s Interagency HIV Study and the AIDS Clinical Trials Group. Dr. Wright is a permanent appointee to the NY State AIDS Advisory Council. He also serves on the board of directors for the AIDS Healthcare Foundation, which cares for over 3 million persons living with HIV in 50 countries.

Dr. Schmitz earned her BS in Nutritional Sciences from Cornell University and her medical degree from SUNY Downstate Medical Center. She completed her Internal Medicine Residency at Temple University Hospital and an Obesity Medicine Fellowship at New York Presbyterian Hospital/Weill Cornell Medical Center, where she joined the faculty in July 2023. Dr. Schmitz is an obesity medicine specialist and clinician-researcher at the Comprehensive Weight Control Center. She is the recipient of a KL2 career development award supporting a prospective pilot study of tirzepatide in postmenopausal hormone receptor-positive breast cancer survivors.

Tatyana Kushner, MD, MSCE, is Associate Professor of Medicine in the Department of Gastroenterology, with joint appointments in the Department of Obstetrics and Gynecology and the Department of Population Health Sciences. Her clinical practice encompasses the full spectrum of liver diseases, with a focus on viral hepatitis (hepatitis B,C, and D) and women with liver disease. Her clinical research program focuses on delineating the epidemiology and outcomes of individuals living with viral hepatitis, such as HBV and delta hepatitis, and developing interventions to optimize detection and treatment of viral hepatitis. Her work has been published in numerous gastroenterology and liver journals.

Emily Frey, MD is an Assistant Professor of Clinical Medicine in the Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine.  Her primary role is as an outpatient geriatrics provider at the Center on Aging, providing primary care to older adults. She also spends time working on the inpatient geriatrics and geriatrics consult services. In addition to her work in primary care for older adults, she has a special interest in HIV and aging, serving as a geriatric consultant for individuals aging with HIV. She is a member of the Glesby & Siegler lab, a collaborative team of specialists from the Divisions of Infectious Diseases and Geriatric Medicine. Their research program focuses on understanding the impact of HIV on older adults to promote healthy aging.  Emily also serves on the Clinical Quality Advisory Committee of the New York State Department of Health AIDS Institute. 

Marshall Glesby, MD, PhD is a Professor of Medicine and Population Health Sciences, Director of the Cornell HIV Clinical Trials Unit, Associate Chief of the Division of Infectious Diseases, and Vice Chair for Faculty Development in the Department of Medicine at Weill Cornell Medical College. He is the Regional Clinical Director of the NECA AETC. He is an Assistant Editor of the Journal of Acquired Immune Deficiency Syndromes and a former member of the Antiviral Drugs Advisory Committee of the Food and Drug Administration (FDA). Dr. Glesby has co-authored over 150 peer reviewed articles.

Dr. Gulick is a Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine and Attending Physician at the New York Presbyterian Hospital in New York City.  He is board certified in internal medicine and infectious diseases.

Dr. Gulick’s research interests include designing, conducting, and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiviral agents with new mechanisms of action.  He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health. 

He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection.   He previously served as the Co-Chair of the NIH COVID-19 Treatment Guidelines Panel, as a Member and as Chair of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and as a Member and as Chair of the NIH Office of AIDS Research Advisory Committee (OARAC).  He is a Member of the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), International AIDS Society (IAS), and the Infectious Diseases Society of America (IDSA) and has presented at national and international meetings and published widely.

Dr. Jason E. Zucker is an Assistant Professor of Medicine in the Division of Infectious Diseases at Columbia University Irving Medical Center Principal Investigator and Co- Medical Director of the New York City STI/STD Prevention Training Center, and Director of Project STAY, services to assist youth. Dual-trained in adult and pediatric infectious diseases, he provides status-neutral HIV prevention and sexual health care across the lifespan at the NewYork-Presbyterian/Columbia Comprehensive Health Program Sexual Health Clinic.

Dr. Zucker's research sits at the intersection of data science, behavioral science, and implementation science, with a focus on improving engagement across the HIV and STI prevention continuum. He is principal investigator of Doxy4STICare, an NIH-funded study of engagement, effective use, and antimicrobial resistance associated with doxycycline post-exposure prophylaxis (Doxy-PEP), and of STIckER, a digital patient decision aid designed to increase STI testing in emergency departments. His PrEP work spans provider-facing strategies to reduce missed opportunities for prevention (Get2PrEP), predictors of disengagement from PrEP care, and implementation of long-acting injectable agents through the ALAI UP and TAIL-PrEP studies.